Cancer Care Ontario | Cancer Care Ontario

96 Results

Guidelines and Advice

Screening for Lynch Syndrome by Immunohistochemistry, BRAF Mutations Analysis, and MLH1 Promoter Methylation Analysis for Patients in Ontario with Colorectal or Endometrial Cancers

Status: Archived
ID: MOAC 3

Sep 2015

Guidelines and Advice

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2015

Status: Current
ID: PET 2015-1

Oct 2015

Guidelines and Advice

Plerixafor for Autologous Hematopoietic Stem Cell Mobilization and Transplantation for Patients in Ontario

Status: Current
ID: SCT-7

Sep 2015

Guidelines and Advice

Follow-up Care and Psychosocial Needs of Survivors of Prostate Cancer

Status: Current
ID: 26-4

Jun 2015

Guidelines and Advice

Risk Reduction of Prostate Cancer with Drugs or Nutritional Supplements

Status: Education and Information
ID: 3-3

May 2012

Guidelines and Advice

Follow-up for Cervical Cancer

Status: In-Review
ID: 4-16
Version: 2

May 2015

Guidelines and Advice

Hepatic, Pancreatic and Biliary Tract Surgical Oncology Standards

Status: In-Review
ID: 17-2 Version 2
Version: 2

Dec 2015

Guidelines and Advice

Optimal Therapy for Patients Diagnosed with Multiple Myeloma and the Role of High-Dose Chemotherapy and Stem Cell Support

Status: Education and Information
ID: 6-6 Version 2
Version: 2

Jan 2012

Guidelines and Advice

Dasatinib for the Treatment of Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia

Status: Archived
ID: 6-23 (CED)

Jan 2012

Guidelines and Advice

The Role of Aromatase Inhibitors in Adjuvant Therapy for Postmenopausal Women with Hormone Receptor-positive Breast Cancer

Status: Archived
ID: 1-18

May 2012

Guidelines and Advice

Rituximab in Lymphoma and Chronic Lymphocytic Leukemia: A Clinical Practice Guideline

Status: Archived
ID: 6-8
Version: 3

Mar 2015

Guidelines and Advice

18-Fluorodeoxyglucose Positron Emission Tomography in the Diagnosis and Staging of Lung Cancer

Status: Current
ID: 7-20 Version 2
Version: 2

Oct 2012

Screening for Lynch Syndrome by Immunohistochemistry, BRAF Mutations Analysis, and MLH1 Promoter Methylation Analysis for Patients in Ontario with Colorectal or Endometrial Cancers

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2015

Plerixafor for Autologous Hematopoietic Stem Cell Mobilization and Transplantation for Patients in Ontario

Follow-up Care and Psychosocial Needs of Survivors of Prostate Cancer

Risk Reduction of Prostate Cancer with Drugs or Nutritional Supplements

Follow-up for Cervical Cancer

Hepatic, Pancreatic and Biliary Tract Surgical Oncology Standards

Optimal Therapy for Patients Diagnosed with Multiple Myeloma and the Role of High-Dose Chemotherapy and Stem Cell Support

Dasatinib for the Treatment of Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia

The Role of Aromatase Inhibitors in Adjuvant Therapy for Postmenopausal Women with Hormone Receptor-positive Breast Cancer

Rituximab in Lymphoma and Chronic Lymphocytic Leukemia: A Clinical Practice Guideline

18-Fluorodeoxyglucose Positron Emission Tomography in the Diagnosis and Staging of Lung Cancer

Pages